Published in Hum Genet on November 01, 1990
Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Genet (1994) 1.10
Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation. EMBO J (1993) 0.86
A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy. J Med Genet (1998) 0.86
Transthyretin Ile 122 and cardiac amyloidosis in African-Americans. 2 case reports. Tex Heart Inst J (1997) 0.83
Haplotype analysis of common transthyretin mutations. Hum Genet (1995) 0.82
Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP. Curr Opin Neurol (2016) 0.81
Homozygosity for the E526V Mutation in Fibrinogen A Alpha-Chain Amyloidosis: The First Report. Case Rep Nephrol (2015) 0.75
MINIATURE escherichia coli CELLS DEFICIENT IN DNA. Proc Natl Acad Sci U S A (1967) 19.02
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet (2001) 11.12
Exposure measurement error in time-series studies of air pollution: concepts and consequences. Environ Health Perspect (2000) 9.30
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature (1999) 7.47
The systemic amyloidoses. N Engl J Med (1997) 7.32
Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med (1994) 6.05
Effects of colchicine and related substances on cell division. Biochem J (1936) 5.80
Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. Genome Res (2001) 5.78
Teratogenicity of high vitamin A intake. N Engl J Med (1995) 5.53
Absorption of guinea pig serum with agar. A method for elimination of itscytotoxicity for murine thymus cells. Transplantation (1970) 5.37
EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis (2008) 4.88
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 4.83
Mouse actin messenger RNAs. Construction and characterization of a recombinant plasmid molecule containing a complementary DNA transcript of mouse alpha-actin mRNA. J Biol Chem (1981) 4.30
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature (1996) 4.04
Three cdg operons control cellular turnover of cyclic di-GMP in Acetobacter xylinum: genetic organization and occurrence of conserved domains in isoenzymes. J Bacteriol (1998) 3.81
Prenatal genetic diagnosis. I. N Engl J Med (1970) 3.67
EULAR recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 3.37
A clinical trial of active management of labor. N Engl J Med (1995) 3.34
Maternal serum AFP secreening. N Engl J Med (1978) 3.17
Coronavirus mRNA synthesis involves fusion of non-contiguous sequences. EMBO J (1983) 3.13
The properties of DNA transferred to minicells during conjugation. Cold Spring Harb Symp Quant Biol (1968) 2.86
Primary cardiac valve tumors. Ann Thorac Surg (1991) 2.85
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM (1998) 2.81
Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 2.78
Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. Proc Natl Acad Sci U S A (1978) 2.78
Defective T cell receptor signaling and CD8+ thymic selection in humans lacking zap-70 kinase. Cell (1994) 2.69
Synthesis of linear plasmid multimers in Escherichia coli K-12. J Bacteriol (1986) 2.65
Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem Biophys Res Commun (1988) 2.65
Threatened survival of academic-based genetic laboratory services. Am J Hum Genet (1992) 2.65
Changing clinical spectrum of splenic abscess. A multicenter study and review of the literature. Am J Surg (1987) 2.63
An exonic mutation in the HuP2 paired domain gene causes Waardenburg's syndrome. Nature (1992) 2.63
Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. The French Study of Aortic Plaques in Stroke Group. N Engl J Med (1996) 2.55
Models of acculturation and health behaviors among Latino immigrants to the US. Soc Sci Med (2001) 2.33
Autistic behavior, FMR1 protein, and developmental trajectories in young males with fragile X syndrome. J Autism Dev Disord (2001) 2.29
Prenatal genetic diagnosis (second of three parts). N Engl J Med (1970) 2.29
EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis (2008) 2.25
The relationship between gastroesophageal reflux and apnea in infants. J Pediatr (2000) 2.24
Prenatal diagnosis of neural tube defects. III. A reevaluation of the alpha-fetoprotein assay. Obstet Gynecol (1977) 2.24
The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey. J Rheumatol (1980) 2.20
A single locus in the mouse encodes both myosin light chains 1 and 3, a second locus corresponds to a related pseudogene. Cell (1984) 2.19
Child health, developmental plasticity, and epigenetic programming. Endocr Rev (2010) 2.15
Postcholecystectomy biliary leaks in the laparoscopic era: risk factors, presentation, and management. McGill Gallstone Treatment Group. Gastrointest Endosc (1997) 2.15
Successful treatment of primary amebic meningoencephalitis. N Engl J Med (1982) 2.14
Further characterization of amyloid-enhancing factor. Lab Invest (1982) 2.12
Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. JAMA (1992) 2.11
Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin Exp Immunol (1979) 2.08
Percutaneous dilational tracheostomy. A bedside procedure on the intensive care unit. Anaesthesia (1991) 2.07
Management of hypertension in angiogenesis inhibitor-treated patients. Ann Oncol (2009) 2.06
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis (2007) 2.01
Predicting relapse in Crohn's disease: a biopsychosocial model. Gut (2008) 2.01
Methotrexate-induced congenital malformations. J Pediatr (1968) 2.00
Non-invasive diagnosis of coronary artery disease by quantitative stress echocardiography: optimal diagnostic models using off-line tissue Doppler in the MYDISE study. Eur Heart J (2003) 1.99
Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects. Drug Metab Dispos (2003) 1.98
Central diabetes insipidus in children and young adults. N Engl J Med (2000) 1.97
Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med (1997) 1.93
Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase. N Engl J Med (1976) 1.91
Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart (1997) 1.90
The arthritis of Behçet's disease: a prospective study. Ann Rheum Dis (1983) 1.86
Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia. Blood (1989) 1.85
Further mapping of markers around the centromere of human chromosome 19. Genomics (1987) 1.84
Quality of community drinking water and the occurrence of spontaneous abortion. Arch Environ Health (1989) 1.83
DNA isolated from Escherichia coli minicells mated with F+ cells. Proc Natl Acad Sci U S A (1968) 1.83
Results and benefits of a maternal serum alpha-fetoprotein screening program. JAMA (1984) 1.82
Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs. JAMA (2001) 1.81
Duty to re-contact. Genet Med (2001) 1.80
Regulation of muscle gene expression. The accumulation of messenger RNAs coding for muscle-specific proteins during myogenesis in a mouse cell line. J Mol Biol (1982) 1.79
Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency disease. Cell (1978) 1.78
Sensitivity, specificity, and predictive value of abdominal fat aspiration for the diagnosis of amyloidosis. Arthritis Rheum (1989) 1.76
Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism. J Biol Chem (1983) 1.74
Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts. Circulation (2001) 1.73
Experimental models for gastric leiomyosarcoma. The effects of N-methyl-N'-nitro-N-nitrosoguanidine in combination with stress, aspirin, or sodium taurocholate. Cancer (1984) 1.73
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology (2001) 1.71
The high prevalence of HLA-B5 in Behçet's disease. Clin Exp Immunol (1977) 1.69
Interplasmidic and intraplasmidic recombination in Escherichia coli K-12. Mol Gen Genet (1981) 1.69
Intracranial arterial dolichoectasia is associated with enlarged descending thoracic aorta. Neurology (2004) 1.69
A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer (1992) 1.68
Herpesvirus hominis infection in patients with myeloproliferative and lymphoproliferative disorders. Br Med J (1972) 1.68
Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci U S A (1998) 1.68
Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. J Am Coll Cardiol (2001) 1.67
Primary osteoarthrosis of the knee or hip. Prevalence of Heberden nodes in relation to age and sex. JAMA (1975) 1.67
Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines. J Exp Med (1988) 1.67
Intrapartum maternal fever and neonatal outcome. Pediatrics (2000) 1.65
Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am J Hum Genet (1993) 1.64
A comparison of risk factors for preterm labor and term small-for-gestational-age birth. Epidemiology (1996) 1.64
Protective autoimmunity is a physiological response to CNS trauma. J Neurosci (2001) 1.64
HLA antigens in Behçet's disease: a reappraisal by a comparative study of Turkish and British patients. Ann Rheum Dis (1980) 1.63
Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res (1999) 1.62
The value of magnetic resonance imaging in our current management of ACL and meniscal injuries. Knee Surg Sports Traumatol Arthrosc (2007) 1.62
Neurologic involvement in Behçet's syndrome. A prospective study. Arch Neurol (1989) 1.62
Nucleotide sequence and spatial expression pattern of a drought- and abscisic Acid-induced gene of tomato. Plant Physiol (1991) 1.62
Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke (2000) 1.62
Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency. J Clin Invest (1978) 1.61
T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci U S A (2000) 1.61
Plasmidic recombination in Escherichia coli K-12: the role of recF gene function. Mol Gen Genet (1983) 1.61
Early development, temperament, and functional impairment in autism and fragile X syndrome. J Autism Dev Disord (2000) 1.60
Myotonic heart disease: a clinical follow-up. Neurology (1991) 1.60
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis. Leukemia (2012) 1.60